The advancing body of research on TREM2 has markedly deepened our comprehension of glioblastoma (GBM) and Alzheimer’s disease (AD), with a particular emphasis on the activation and inflammatory response of microglia/macrophages. This evidence concerns the gene TREM2 and glioblastoma.